MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1478-3231.2006.01420.x

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2007

Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.

Ohki Takamasa, Tateishi Ryosuke, Shiina Shuichiro, Sato Takahisa, Masuzaki Ryota, Yoshida Hideo, Kanai Fumihiko, Obi Shuntaro, Yoshida Haruhiko, Omata Masao

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Overweight and hepatic steatosis can increase the risk of hepatocarcinogenesis. In addition, overweight may affect the treatment efficacy of ultrasound-guided percutaneous ablation. We evaluated the impact of overweight on the safety and efficacy of percutaneous ablation to hepatocellular carcinoma (HCC).

METHODS

We enrolled 743 patients with naïve HCC who were treated by percutaneous ablation including ethanol injection, microwave coagulation, and radiofrequency ablation (RFA) between 1995 and 2003. Patients were divided into two groups by body mass index (BMI): 219 overweight patients with BMI>25 kg/m2 and 524 control patients with BMI<or=25 kg/m2. The effects of BMI on complications of percutaneous ablation, HCC recurrence, and overall survival were analyzed, together with others including tumor and liver function-related factors.

RESULTS

The overweight group required a significantly larger number of sessions by RFA (P=0.01). Major complications were identified in 8.7% in the overweight group and 7.6% in the control group (P=0.94). There was no significant difference in cumulative recurrence rate and local tumor-progression rate between the two groups (P=0.63 and 0.44). Cumulative survival rates at 1, 3, and 5 years were 95.4%, 75.7%, and 57.8%, respectively, in the overweight group and 94.1%, 78.0%, and 58.8% in the control group (P=0.99).

CONCLUSIONS

The results indicated that overweight did not increase complications nor affect HCC recurrence and overall survival. However, the number of sessions of RFA was significantly greater in overweight patients, suggesting that overweight was associated with minor technical difficulties.

Для цитирования: Ohki Takamasa, Tateishi Ryosuke, Shiina Shuichiro, Sato Takahisa, Masuzaki Ryota, Yoshida Hideo, Kanai Fumihiko, Obi Shuntaro, Yoshida Haruhiko, Omata Masao. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.. Liver international : official journal of the International Association for the Study of the Liver. 2007. DOI: 10.1111/j.1478-3231.2006.01420.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.